AMR vs Angola: Hepatitis B surface antigen (HBsAg) prevalence
AMR
0.0%
in 2024
Angola
3.1%
in 2024
AMR rank
7th
Angola rank
5th
Hepatitis B surface antigen (HBsAg) prevalence over time
- AMR
- Angola
How they compare
Angola currently reports 3.1% against 0.0% in AMR, a difference of 3.1%.
Across all 10 years both countries report, Angola has been ahead every year.
AMR ranks 7th and Angola ranks 5th of 7 groups.
Angola has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | AMR | Angola | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.0% | 2.6% | 2.6% | Angola |
| 2020s | 0.0% | 3.0% | 3.0% | Angola |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, AMR or Angola?
- Angola, at 3.1% against 0.0% in AMR as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between AMR and Angola?
- 3.1%, with Angola ahead.
- How many years of comparable data are there for AMR and Angola?
- 10 years are reported by both, from 2015 to 2024.
- How do AMR and Angola rank globally for hepatitis b surface antigen (hbsag) prevalence?
- AMR ranks 7th and Angola ranks 5th of 7 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.